Boxer Capital’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-4,000,000
| Closed | -$17.4M | – | 103 |
|
|
2021
Q2 | $17.4M | Hold |
4,000,000
| – | – | 0.62% | 52 |
|
|
2021
Q1 | $18.2M | Hold |
4,000,000
| – | – | 0.62% | 47 |
|
|
2020
Q4 | $23M | Hold |
4,000,000
| – | – | 0.74% | 38 |
|
|
2020
Q3 | $29M | Buy |
4,000,000
+2,000,000
| +100% | +$14.5M | 1% | 29 |
|
|
2020
Q2 | $6.98M | Hold |
2,000,000
| – | – | 0.31% | 52 |
|
|
2020
Q1 | $2.96M | Hold |
2,000,000
| – | – | 0.2% | 56 |
|
|
2019
Q4 | $3.92M | Buy |
2,000,000
+750,000
| +60% | +$1.47M | 0.22% | 45 |
|
|
2019
Q3 | $6.4M | Hold |
1,250,000
| – | – | 0.46% | 39 |
|
|
2019
Q2 | $8.95M | Hold |
1,250,000
| – | – | 0.77% | 23 |
|
|
2019
Q1 | $16.6M | Sell |
1,250,000
-844,000
| -40% | -$11.2M | 1.92% | 16 |
|
|
2018
Q4 | $16.5M | Hold |
2,094,000
| – | – | 2.04% | 14 |
|
|
2018
Q3 | $23.2M | Hold |
2,094,000
| – | – | 2.57% | 13 |
|
|
2018
Q2 | $28.1M | Sell |
2,094,000
-618,986
| -23% | -$8.31M | 3.18% | 12 |
|
|
2018
Q1 | $35.2M | Buy |
2,712,986
+1,700,000
| +168% | +$22.1M | 3.76% | 12 |
|
|
2017
Q4 | $9.32M | Hold |
1,012,986
| – | – | 1.7% | 16 |
|
|
2017
Q3 | $8.17M | Buy |
1,012,986
+587,986
| +138% | +$4.74M | 1.86% | 14 |
|
|
2017
Q2 | $2.45M | Sell |
425,000
-352,202
| -45% | -$2.03M | 0.58% | 22 |
|
|
2017
Q1 | $3.34M | Buy |
+777,202
| New | +$3.34M | 0.73% | 18 |
|